Home › Companies › Insmed Incorporated › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Insmed Incorporated’s Form 8-K, filed May 15, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 13, 2026: 4 items on Insmed Incorporated’s Form 8-K, filed May 15, 2026: 2 approved · 2 passed (calculated).
Notable dissent: 2 directors (17.3%, 11.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Insmed Incorporated in the interactive database Compare manager voting policies
These tallies are Insmed Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Elizabeth McKee Anderson | 153,734,471 | -- | -- | 32,130,980 | 11,564,082 | 83% | Passed (calculated) | — |
| Elect Director: Clarissa Desjardins, Ph.D. | 164,437,828 | -- | -- | 21,427,623 | 11,564,082 | 88% | Passed (calculated) | — |
| 2. Advisory Vote on the 2025 Compensation of Named Executive Officers | 162,133,728 | 23,657,325 | 74,398 | -- | 11,564,082 | 87% | Approved | — |
| 3. Ratification of the Appointment of an Independent Registered Public Accounting Firm | 190,386,612 | 6,997,613 | 45,308 | -- | -- | 96% | Approved | — |
Source: Insmed Incorporated, Form 8-K, filed with the SEC on May 15, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
638 asset managers disclosed a vote on at least one Insmed Incorporated item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 12 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D.
Insmed Incorporated’s own tally for this item (“Elect Director: Clarissa Desjardins, Ph.D.”): 164,437,828 for, 21,427,623 withheld, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 156 asset managers below reported 83,968,115 for, 2,847,814 withheld, 17,266 abstained, 163 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,079,762 | 0 | 90 | 0 | For |
| JPMorgan | 14,732,012 | 0 | 0 | 0 | For |
| Fidelity | 13,606,000 | 0 | 0 | 0 | For |
| Invesco | 6,247,157 | 0 | 0 | 0 | For |
| BlackRock | 5,850,807 | 0 | 0 | 0 | For |
| Capital Group | 4,716,397 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 2,221,489 | Withhold |
| Columbia Threadneedle | 1,946,885 | 0 | 0 | 0 | For |
| Charles Schwab | 1,013,492 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 850,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 777,196 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 687,831 | 0 | 0 | 0 | For |
| American Century | 680,542 | 0 | 0 | 0 | For |
| Waddell & Reed | 657,272 | 0 | 0 | 0 | For |
| Jackson National | 650,188 | 0 | 0 | 0 | For |
| State Street | 606,348 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 551,328 | 0 | 0 | 0 | For |
| Victory Capital | 519,578 | 0 | 0 | 0 | For |
| Equitable | 327,172 | 0 | 0 | 178,413 | Mixed |
| CARILLON SERIES TRUST | 500,953 | 0 | 0 | 0 | For |
| TIAA | 471,703 | 0 | 0 | 0 | For |
| Lord Abbett | 452,286 | 0 | 0 | 0 | For |
| Principal | 412,285 | 0 | 0 | 0 | For |
| Federated Hermes | 374,598 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 352,531 | 0 | 0 | 0 | For |
Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).
Combines 13 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee Anderson
Insmed Incorporated’s own tally for this item (“Elect Director: Elizabeth McKee Anderson”): 153,734,471 for, 32,130,980 withheld, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 156 asset managers below reported 82,987,900 for, 3,760,272 withheld, 85,023 abstained, 163 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,062,833 | 0 | 128 | 16,891 | For |
| JPMorgan | 14,732,012 | 0 | 0 | 0 | For |
| Fidelity | 13,606,000 | 0 | 0 | 0 | For |
| Invesco | 6,247,157 | 0 | 0 | 0 | For |
| BlackRock | 5,850,807 | 0 | 0 | 0 | For |
| Capital Group | 4,716,397 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 2,221,489 | Withhold |
| Columbia Threadneedle | 1,946,885 | 0 | 0 | 0 | For |
| Charles Schwab | 1,013,492 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 850,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 777,196 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 687,831 | 0 | 0 | 0 | For |
| American Century | 680,542 | 0 | 0 | 0 | For |
| Waddell & Reed | 657,272 | 0 | 0 | 0 | For |
| Jackson National | 647,765 | 0 | 2,423 | 0 | For |
| State Street | 1,752 | 0 | 0 | 604,596 | Withhold |
| MUTUAL FUND SERIES TRUST | 551,328 | 0 | 0 | 0 | For |
| Victory Capital | 519,578 | 0 | 0 | 0 | For |
| Equitable | 327,172 | 0 | 0 | 178,413 | Mixed |
| CARILLON SERIES TRUST | 500,953 | 0 | 0 | 0 | For |
| TIAA | 471,703 | 0 | 0 | 0 | For |
| Lord Abbett | 452,286 | 0 | 0 | 0 | For |
| Principal | 412,285 | 0 | 0 | 0 | For |
| Federated Hermes | 374,598 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 352,531 | 0 | 0 | 0 | For |
Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
87% Approved · of votes cast
Prior year: 96.6% for (May 15, 2025 meeting) ▼ 9.3 pts
Description as filed by funds: An advisory vote on the 2025 compensation of our named executive officers.
Insmed Incorporated’s own tally for this item (“2. Advisory Vote on the 2025 Compensation of Named Executive Officers”): 162,133,728 for, 23,657,325 against — passed, per its Form 8-K filed May 15, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,079,755 | 96 | 0 | 0 | For |
| JPMorgan | 14,732,012 | 0 | 0 | 0 | For |
| Fidelity | 13,606,000 | 0 | 0 | 0 | For |
| Invesco | 6,247,157 | 0 | 0 | 0 | For |
| BlackRock | 5,850,807 | 0 | 0 | 0 | For |
| Capital Group | 4,716,397 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,930,814 | 290,675 | 0 | 0 | Mixed |
| Columbia Threadneedle | 1,946,885 | 0 | 0 | 0 | For |
| Charles Schwab | 1,013,492 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 850,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 777,196 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 687,831 | 0 | 0 | 0 | For |
| American Century | 680,542 | 0 | 0 | 0 | For |
| Waddell & Reed | 657,272 | 0 | 0 | 0 | For |
| Jackson National | 650,188 | 0 | 0 | 0 | For |
| State Street | 606,348 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 551,328 | 0 | 0 | 0 | For |
| Victory Capital | 519,578 | 0 | 0 | 0 | For |
| Equitable | 505,585 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 500,953 | 0 | 0 | 0 | For |
| TIAA | 471,703 | 0 | 0 | 0 | For |
| Lord Abbett | 452,286 | 0 | 0 | 0 | For |
| Principal | 412,285 | 0 | 0 | 0 | For |
| Federated Hermes | 374,598 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 352,531 | 0 | 0 | 0 | For |
Fund voting reports, all 153 managers: 86,403,643 for, 404,274 against, 6,647 abstained, 163 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 0 | 17,163,874 | 0 | 0 | Against |
| Fidelity | 12,368,145 | 703,849 | 0 | 0 | Mixed |
| BlackRock | 7,746,889 | 44 | 0 | 0 | For |
| Invesco | 7,051,550 | 0 | 0 | 0 | For |
| Artisan | 5,369,463 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 4,842,880 | 0 | 0 | 0 | For |
| Capital Group | 4,818,897 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 4,412,370 | 0 | 0 | 0 | For |
| State Street | 4,374,913 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,978,517 | 418,885 | 0 | 0 | Mixed |
| Orbis Allan Gray Ltd | 2,605,782 | 0 | 0 | 0 | For |
| JPMorgan | 2,454,471 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 2,400,080 | 0 | 0 | 0 | For |
| DE Shaw | 1,720,005 | 0 | 0 | 0 | For |
| Vanguard | 1,641,633 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,176,583 | 0 | 0 | 0 | For |
| Charles Schwab | 1,134,043 | 0 | 0 | 0 | For |
| Northern Trust | 1,109,267 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 1,076,813 | 0 | 0 | 0 | For |
| Duquesne Family Office LLC | 1,008,266 | 0 | 0 | 0 | For |
| Amundi | 0 | 992,373 | 0 | 0 | Against |
| Castle Hook Partners LP | 908,452 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 876,466 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 851,855 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 799,269 | 0 | 0 | 0 | For |
Institutional-manager reports, all 521 managers: 101,987,993 for, 22,928,600 against, 5,583 abstained, 8,741 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Approved · of votes cast
Prior year: 96.8% for (May 15, 2025 meeting) ▼ 0.3 pts
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.
Insmed Incorporated’s own tally for this item (“3. Ratification of the Appointment of an Independent Registered Public Accounting Firm”): 190,386,612 for, 6,997,613 against — passed, per its Form 8-K filed May 15, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 157 asset managers below reported 86,579,980 for, 167,782 against, 6,647 abstained, 163 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,062,933 | 16,918 | 0 | 0 | For |
| JPMorgan | 14,732,012 | 0 | 0 | 0 | For |
| Fidelity | 13,606,000 | 0 | 0 | 0 | For |
| Invesco | 6,247,157 | 0 | 0 | 0 | For |
| BlackRock | 5,850,807 | 0 | 0 | 0 | For |
| Capital Group | 4,716,397 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,221,489 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,946,885 | 0 | 0 | 0 | For |
| Charles Schwab | 1,013,492 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 850,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 777,196 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 687,831 | 0 | 0 | 0 | For |
| American Century | 680,542 | 0 | 0 | 0 | For |
| Waddell & Reed | 657,272 | 0 | 0 | 0 | For |
| Jackson National | 650,188 | 0 | 0 | 0 | For |
| State Street | 606,327 | 21 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 551,328 | 0 | 0 | 0 | For |
| Victory Capital | 519,578 | 0 | 0 | 0 | For |
| Equitable | 505,585 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 500,953 | 0 | 0 | 0 | For |
| TIAA | 471,703 | 0 | 0 | 0 | For |
| Lord Abbett | 452,286 | 0 | 0 | 0 | For |
| Principal | 412,285 | 0 | 0 | 0 | For |
| Federated Hermes | 374,598 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 352,531 | 0 | 0 | 0 | For |
Showing the 25 largest of 157 asset managers. All 157 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 216,521,841 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.27% |
| 2 | JPMorgan | 6.80% |
| 3 | Fidelity | 6.28% |
| 4 | Invesco | 2.89% |
| 5 | BlackRock | 2.70% |
| 6 | Capital Group | 2.18% |
| 7 | T. Rowe Price | 1.03% |
| 8 | Columbia Threadneedle | 0.90% |
| 9 | Charles Schwab | 0.47% |
| 10 | Franklin Custodian Funds | 0.39% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Darwin Global Management, Ltd. | 7.93% |
| 2 | Fidelity | 6.04% |
| 3 | BlackRock | 3.58% |
| 4 | Invesco | 3.26% |
| 5 | Artisan | 2.48% |
| 6 | RTW INVESTMENTS, LP | 2.24% |
| 7 | Capital Group | 2.23% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.04% |
| 9 | State Street | 2.02% |
| 10 | T. Rowe Price | 1.57% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| JPMorgan Chase | 24,150,499 | 11.15% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 21,076,344 | 9.73% | Form 13F, quarter ended March 31, 2026 |
| BlackRock | 16,678,146 | 7.70% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 13,160,167 | 6.08% | Form 13F, quarter ended March 31, 2026 |
| Darwin Global Management, Ltd. | 6,431,163 | 2.97% | Schedule 13G, filed August 14, 2026 |
| D.E. Shaw | 5,642,725 | 2.61% | Form 13F, quarter ended March 31, 2026 |
| State Street | 5,551,699 | 2.56% | Form 13F, quarter ended March 31, 2026 |
| T. Rowe Price | 3,092,807 | 1.43% | Form 13F, quarter ended March 31, 2026 |
| Franklin Templeton | 2,617,251 | 1.21% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 216,521,841 shares outstanding, as reported by Insmed Incorporated on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Insmed Incorporated's shareholder meeting held May 13, 2026, in the 2025-2026 proxy season, 638 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 3,740 separate fund positions. On the most widely held item on that ballot — An advisory vote on the 2025 compensation of our named executive officers. — Insmed Incorporated's filing reports the proposal as approved, with 87% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Insmed Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Insmed Incorporated’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Insmed Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Insmed (INSM) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/insmed-incorporated/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.